arrow
L

Louise M. Burrell

institute for breathing & sleep (ibas)
H指数:57
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis

肥厚型心肌病患者使用心肌肌球蛋白抑制剂后短期房颤的发生率和风险:一项系统评价和荟萃分析

2025-08-280
PRE
Fludrocortisone dose-response relationship in septic shock: a randomised phase II trial

氟氢可的松治疗脓毒症休克的剂量-反应关系: 一项随机II期试验

2024-09-053
OAAI
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension

高血压的生活方式管理:由世界高血压联盟和欧洲高血压学会支持的国际高血压学会立场文件

2023-09-1278
OAAI
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 (vol 13, 889372, 2022)

Fc工程ACE2-Fc是一种有效的多功能剂靶向SARS-CoV2 (vol 13,889372,2022)

2023-01-100
OAAI
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

血管紧张素受体阻滞剂治疗新型冠状病毒肺炎: 实用性、适应性、多中心、3期、随机对照试验

2022-11-1623
OAAI
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

Fc工程ACE2-Fc是一种有效的多功能药物靶向SARS-CoV2

2022-07-287
OAAI